Table of Contents
May 01, 2004; Volume 71, Issue 5 suppl 3Optimizing Adherence to Therapy in Hepatitis C: Challenges and Emerging Strategies
-
Foreword
-
Foreword
Zobair M. Younossi, MD, MPH- Cleveland Clinic Journal of Medicine May 2004, 71 (5 suppl 3) S2;
-
-
Article
-
The evolving treatment of chronic hepatitis C: Where we stand a decade out
Sherif Saadeh, MD and Gary L. Davis, MD- Cleveland Clinic Journal of Medicine May 2004, 71 (5 suppl 3) S3-S7;
-
Initial treatment for chronic hepatitis C
Keyur Patel, MD and John G. McHutchison, MD- Cleveland Clinic Journal of Medicine May 2004, 71 (5 suppl 3) S8-S12;
-
Retreatment of patients who do not respond to initial therapy for chronic hepatitis C
Mitchell L. Shiffman, MD- Cleveland Clinic Journal of Medicine May 2004, 71 (5 suppl 3) S13-S16;
-
Managing the hematologic side effects of antiviral therapy for chronic hepatitis C
Janus P. Ong, MD and Zobair M. Younossi, MD, MPH- Cleveland Clinic Journal of Medicine May 2004, 71 (5 suppl 3) S17-S21;
-
The role of hematopoietic growth factors in special populations with chronic hepatitis C
Stevan A. Gonzalez, MD and Ira M. Jacobson, MD- Cleveland Clinic Journal of Medicine May 2004, 71 (5 suppl 3) S22-S26;
-
Managing the neuropsychiatric side effects of interferon-based therapy for hepatitis C
Catherine C. Crone, MD, Geoffrey M. Gabriel, MD and Thomas N. Wise, MD- Cleveland Clinic Journal of Medicine May 2004, 71 (5 suppl 3) S27-S32;
-
The role of physician extenders in managing patients with chronic hepatitis C
Harpreet Gujral, RN, MSN, CRNP, Carla Viscomi, RN, BSN and Rochelle Collantes, MD, MPH- Cleveland Clinic Journal of Medicine May 2004, 71 (5 suppl 3) S33-S37;
-


